Document ID: chunk:federal_register_of_legislation:F2025C00158:clause:4_1:p26
Version: federal_register_of_legislation:F2025C00158
Segment Type: clause
Provision Reference: sch 4 cl 1 (pt 26/191)
Character Range: 9742205–9754180

restriction before being able to qualify for treatment under the continuing restriction.
                                                                                                                                                                                                                               The name of the consulting psychiatrist should be included in the patient's medical records.
                                                                                                                                                                                                                               A medical practitioner should request a quantity sufficient for up to one month's supply. Up to 5 repeats will be authorised.
C5027               P5027          CN5027           Follitropin alfa                                                                                                                                                           Assisted Reproductive Technology                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         Compliance with Authority Required procedures - Streamlined Authority Code 5027
                                                                                                                                                                                                                               Patient must be receiving medical services as described in items 13200, 13201, 13202 or 13203 of the Medicare Benefits Schedule.
                                                    Follitropin beta

                                                    Follitropin delta

                                                    Human menopausal gonadotrophin

C5036               P5036          CN5036           Entecavir                                                                                                                                                                  Chronic hepatitis B infection                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            Compliance with Authority Required procedures - Streamlined Authority Code 5036
                                                                                                                                                                                                                               Patient must have cirrhosis; AND
                                                    Lamivudine                                                                                                                                                                 Patient must have detectable HBV DNA.
                                                                                                                                                                                                                               Patients with Child's class B or C cirrhosis (ascites, variceal bleeding, encephalopathy, albumin less than 30 g per L, bilirubin greater than 30 micromoles per L) should have their treatment discussed with a transplant unit prior to initiating therapy.
C5037               P5037          CN5037           Entecavir                                                                                                                                                                  Chronic hepatitis B infection                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            Compliance with Authority Required procedures - Streamlined Authority Code 5037
                                                                                                                                                                                                                               Patient must have cirrhosis; AND
                                                                                                                                                                                                                               Patient must have failed lamivudine; AND
                                                                                                                                                                                                                               Patient must have detectable HBV DNA.
                                                                                                                                                                                                                               Patients with Child's class B or C cirrhosis (ascites, variceal bleeding, encephalopathy, albumin less than 30 g per L, bilirubin greater than 30 micromoles per L) should have their treatment discussed with a transplant unit prior to initiating therapy.
C5038               P5038          CN5038           Bimatoprost with timolol                                                                                                                                                   Elevated intra-ocular pressure
                                                                                                                                                                                                                               The condition must have been inadequately controlled with monotherapy; AND
                                                    Brimonidine with timolol                                                                                                                                                   Patient must have open-angle glaucoma.  or
                                                                                                                                                                                                                               Patient must have ocular hypertension.
                                                    Brinzolamide with brimonidine

                                                    Brinzolamide with timolol

                                                    Dorzolamide with timolol

                                                    Latanoprost with timolol

                                                    Travoprost with timolol

C5044               P5044          CN5044           Entecavir                                                                                                                                                                  Chronic hepatitis B infection                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            Compliance with Authority Required procedures - Streamlined Authority Code 5044
                                                                                                                                                                                                                               Patient must not have cirrhosis; AND
                                                                                                                                                                                                                               Patient must have failed lamivudine; AND
                                                                                                                                                                                                                               Patient must have repeatedly elevated serum ALT levels while on concurrent antihepadnaviral therapy of greater than or equal to 6 months duration, in conjunction with documented chronic hepatitis B infection.  or
                                                                                                                                                                                                                               Patient must have repeatedly elevated HBV DNA levels one log greater than the nadir value or failure to achieve a 1 log reduction in HBV DNA within 3 months whilst on previous antihepadnaviral therapy, except in patients with evidence of poor compliance.
C5045               P5045          CN5045           Progesterone                                                                                                                                                               Assisted Reproductive Technology                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         Compliance with Authority Required procedures - Streamlined Authority Code 5045
                                                                                                                                                                                                                               The treatment must be for luteal phase support as part of an assisted reproductive technology (ART) treatment cycle for infertile women; AND
                                                                                                                                                                                                                               Patient must be receiving medical services as described in items 13200 or 13201 of the Medicare Benefits Schedule.
                                                                                                                                                                                                                               The luteal phase is defined as the